| abstract |
Fragments of blood coagulation factor IX with an intact EGF and Gla domain without factor IX coagulation activity, not chemically modified and a molecular weight between approx. 12,000 and 50,000 D, obtainable by proteolytic cleavage, as an active ingredient with antithrombotic activity and processes for their preparation, their use in the manufacture of medicinal products and these medicinal products themselves. |